Список использованной литературы
1 Насонов Е.Л., Скрипникова И.А., Насонова В.А. Проблема остеопороза в ревматологии. М., Стин, 1997, 540 с.
2 Руководство по остеопорозу. Под ред. д.м.н., проф. Л.И.Беневоленской, 2003, 524с.
3 Brosch S, Redlich K, Pietschmann P. Pathogenesis of osteoporosis in rheumatoid arthritis. Acta Med Austriaca. 2003;30(1); С.1–5.
4. Gravallese E M. Bone destruction in arthritis. Annals of the Rheumatic Diseases 2002; 61; С.84–86
5 Haugeberg G, Orstavik RE, Uhlig T et al. Bone loss in patients with rheumatoid arthritis: results from a population–based cohort of 366 patients followed up for two years. Arthritis Rheum. 2002 Jul; 46(7); С. 1720–8.
6 Jensen T,Klarlund M,Hansen M et al. Bone loss in unclassified polyarthritis and early rheumatoid arthritis is better detected by digital x ray radiogrammetry than dual x ray absorptiometry: relationship with disease activity and radiographic outcome. Annals of the Rheumatic Diseases 2004; 63; С.15–22.
7 Kelly C, Bartholomew P, Lapworth A et al. Peripheral bone density in patients with rheumatoid arthritis and factors which influence it. Eur J Intern Med. 2002 Oct; 13(7); С.423.
8 Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al., Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014; 20; 506(7488); С.376-381.
9 Livshits G, Deng HW, Nguyen TV, Yakovenko K, Recker RR, Eisman JA. Genetics of bone mineral density: evidence for a major pleiotropic effect from an intercontinental study. J Bone Miner Res. 2004; 19(6); С.914-923.
10 Raychaudhuri S. Recent advances in the genetics of rheumatoid arthritis. Curr Opin Rheumatol. 2010; 22(2); С.109-118.
11 Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 7; 447(7145); С.661-678.
12 Julia A, Ballina J, Cañete JD, Balsa A, Tornero-Molina J, Naranjo A, et al., Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility. Arthritis Rheum. 2008; 58(8); С.2275-2286.
13 Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al., Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010; 42(6); С.508-14.
14 Jiang L, Yin J, Ye L, Yang J, Hemani G, Liu AJ, et al., Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans. Arthritis Rheumatol. 2014; 66(5); С.1121-32.
15 Stahl EA, Wegmann D, Trynka G, Gutierrez-Achury J, Do R, Voight BF, et al., Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet. 2012; 44(5); С.483-489.
16 Viatte S, Plant D, Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol. 2013; 9(3); С.141-153.
17 Murariu RV, Macovei LA, Brujbu IC. Osteoporosis in rheumatoid arthritis. Rev Med Chir Soc Med Nat Iasi. 2013;117(2); С.394-403.
18 Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al., Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007;13(2); С.156-63.
19 Schett G, Zwerina J, David JP. The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol. 2008;4(9); С.473-80.
20 Sapir-Koren R, Livshits G. Is interaction between age-dependent decline in mechanical stimulation and osteocyte-estrogen receptor levels the culprit for postmenopausal-impaired bone formation? Osteoporos Int. 2013;24(6); С.1771-89.
21 Sapir-Koren R, Livshits G. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Osteoporos Int. 2014. [Epub ahead of print]
22 Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, et al., A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med. 2007;4(9); С.e278.
23 Kochi Y, Suzuki A, Yamamoto K. Genetic basis of rheumatoid arthritis: A current review. Biochem Biophys Res Commun. 2014 Jul 29. pii: S0006-291X(14)01327-8. [Epub ahead of print]
24 Zhang X, Li W, Zhang X, Zhang X, Jiang L, Guo Y, Wang X. Association between polymorphism in TRAF1/C5 gene and risk of rheumatoid arthritis: a meta-analysis. Mol Biol Rep. 2014;41(1):317-24.
25 Arkema EV, Goldstein BL, Robinson W, Sokolove J, Wagner CA, Malspeis S, Rosner B, Grodstein F, Karlson EW, Costenbader KH. Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study. Arthritis Res Ther. 2013;15(5); С.R159
26 Karlson EW, van Schaaardenburg D, van der Helm-van Mil AH. Strategies to predict rheumatoid arthritis development in at-risk populations. Rheumatology (Oxford). 2014 Aug 4. [Epub ahead of print]
27 Miossec P, Verweij CL, Klareskog L, Pitzalis C, Barton A, Lekkerkerker F, et al. ; Group for Respect of Ethics and Excellence in Science (GREES). Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies. Ann Rheum Dis. 2011;70(10); С.1713-8.
28 Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, et al. Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis. Rheumatology (Oxford). 2002;41(4); С.430-9.
Приложение А
